Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Former Novartis man becomes GSK’s new medical director

May 8, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Shannon, Novartis

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …
Appointment
Roche image

Roche abandons Phase III cholesterol drug

May 8, 2012 Medical Communications, Research and Development, Sales and Marketing CETP inhibitor, Roche, cardiovascular, dalcetrapib, phase III failure

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …
News
GSK picture

GSK signs deal with academics

May 4, 2012 Research and Development, Sales and Marketing Cancer, GSK, PROTAC, Yale, academia

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …
News

GSK appoints two non-executive directors to its Board

May 3, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Jing Ulrich, Lynn Elsenhans

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …
Appointment

Oxford BioTherapeutics appoints new chief operations officer

May 3, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Oxford Biotherapeutics

Oxford BioTherapeutics (OBT) has appointed Dr Esteban Pombo-Villar as its new chief operations officer (COO). In this position he will …
Appointment

Professional regulation – a DIY job?

May 2, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CPD, GMC, Les Rose, drug discovery, regulation

What would happen if we had no drug regulatory bodies, such as the MHRA and the EMA? Can you imagine …
Feature

Lilly invests in UK research base

May 2, 2012 Research and Development Elil Lilly, Erl Wood, neuroscience

Eli Lilly has officially opened new research facilities at its R&D base in Erl Wood in Surrey.The site near Woking …
News

Targacept cuts workforce

May 1, 2012 Research and Development, Sales and Marketing AstraZeneca, MDD, TC-5214, Targecept

The fall-out from pipeline difficulties has led US biopharma company Targacept to make almost half its workforce redundant. In March …
News

EMA eSubmission Gateway now live

May 1, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; ectd

Following a successful pilot, the European Medicines Agency (EMA) has announced that its eSubmission Gateway is now live for all …
News
Press release

Contract research news in brief

May 1, 2012 Research and Development BML, Cetero Labs, Covance, Harlan and Chiltern, PRA

A round-up of recent developments in the contract research sector, featuring updates from PRA, Cetero Labs, Covance/BML, Harlan Labs CRS …
News

Actelion boosted by trial success

April 30, 2012 Research and Development, Sales and Marketing Actelion, Tracleer, almorexant, macitentan

Actelion’s pulmonary arterial hypertension drug macitentan has met its primary endpoint in a Phase III trial.  The news comes after …
News

New ABPI president appointed

April 30, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, MSD UK, appointment

Deepak Khanna, senior vice president and MSD UK managing director, has been appointed as President of the Association of the …
Appointment

New head at Bayer’s Animal Health division

April 27, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer Healthcare, Dirk Ehle, animal health

Dr Dirk Ehle has been appointed Head of the Animal Health Division of Bayer.  The 42-year-old succeeds Dr Jean-Luc Lowinski, …
Appointment

Brennan bows to pressure and quits AstraZeneca

April 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, David Brennan, Q1, pharma

AstraZeneca’s chief executive David Brennan is to step down from his post following mounting dissatisfaction with his leadership. Brennan, who …
News
Boehringer Ingelheim image

A family business: Pradaxa success lifts Boehringer

April 25, 2012 Research and Development, Sales and Marketing Boehringer Ingelheim

Rapid uptake of anti-clotting drug Pradaxa in the US has helped Boehringer Ingelheim enjoy a strong year, and looks set to …
Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025